|4Feb 15, 9:00 PM ET

Dispersyn Gerrit 4

4 · Phio Pharmaceuticals Corp. · Filed Feb 15, 2019

Insider Transaction Report

Form 4
Period: 2019-02-13
Dispersyn Gerrit
Chief Development Officer
Transactions
  • Award

    Common stock

    2019-02-13+55,00071,350 total
Footnotes (1)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION